Part,  Chapter, Paragraph

 1   II,     5.  5.  3|    examination ~329/348 ~3.9/3.2~Eriksson and Koivikko, 1997 (*) /~
 2   II,     5.  5.  3|   unclassified syndromes (5-10%)(Eriksson & Koivikko, 1997; Sidenvall
 3   II,     5.  5.  3| Lithuania. Brain Dev 19:379-387.~Eriksson KJ., Koivikko MJ (1997):
 4   II,     5.  8.  7|            Bergdahl IA, Toren K, Eriksson K, Hedlund U, Nilsson T,
 5   II,     5.  8.  7|         1544-1552.~ ~Lindberg A, Eriksson B, Larsson LG, Ronmark E,
 6   II,     7.  7    |          Sharma G.~ ~Racioppi F, Eriksson L, Tingvall C, Villaveces
 7  III,    10.  2.  5|       death (Barker et al, 2005, Eriksson et al, 2006). Longitudinal
 8  III,    10.  2.  5|           Forsén TJ, Kajantie E, Eriksson JG (2005): Trajectories
 9  III,    10.  2.  5|       Prev Med 1998;27:168-71.~ ~Eriksson JG, Osmond C, Kajantie E,
10  III,    10.  2.  5|    Forsen T, Osmond C, Barker D, Eriksson J (2001): Association of